These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10469215)

  • 1. Protein expression and genetic alterations of p53 and ras in intrahepatic cholangiocarcinoma.
    Furubo S; Harada K; Shimonishi T; Katayanagi K; Tsui W; Nakanuma Y
    Histopathology; 1999 Sep; 35(3):230-40. PubMed ID: 10469215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsatellite instability and alternative genetic pathway in intrahepatic cholangiocarcinoma.
    Momoi H; Itoh T; Nozaki Y; Arima Y; Okabe H; Satoh S; Toda Y; Sakai E; Nakagawara K; Flemming P; Yamamoto M; Shimahara Y; Yamaoka Y; Fukumoto M
    J Hepatol; 2001 Aug; 35(2):235-44. PubMed ID: 11580146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma.
    Oda Y; Sakamoto A; Satio T; Kawauchi S; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2000 Sep; 13(9):994-1004. PubMed ID: 11007040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of p53 and K-ras, and loss of heterozygosity of APC in intrahepatic cholangiocarcinoma.
    Kang YK; Kim WH; Lee HW; Lee HK; Kim YI
    Lab Invest; 1999 Apr; 79(4):477-83. PubMed ID: 10212000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP53 mutations and mdm2 protein overexpression in cholangiocarcinomas.
    Della Torre G; Pasquini G; Pilotti S; Alasio L; Civelli E; Cozzi G; Milella M; Salvetti M; Pierotti MA; Severini A
    Diagn Mol Pathol; 2000 Mar; 9(1):41-6. PubMed ID: 10718212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 and p21/Waf1 protein expression and K-ras codon 12 mutation in carcinoma of the papilla of Vater.
    Zhao B; Kimura W; Futakawa N; Muto T; Kubota K; Harihara Y; Takayama T; Makuuchi M
    Am J Gastroenterol; 1999 Aug; 94(8):2128-34. PubMed ID: 10445539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. K-ras oncogene subtype mutations are associated with survival but not expression of p53, p16(INK4A), p21(WAF-1), cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinoma.
    Kawesha A; Ghaneh P; Andrén-Sandberg A; Ograed D; Skar R; Dawiskiba S; Evans JD; Campbell F; Lemoine N; Neoptolemos JP
    Int J Cancer; 2000 Nov; 89(6):469-74. PubMed ID: 11102889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat.
    Belinsky SA; Middleton SK; Picksley SM; Hahn FF; Nikula KJ
    Radiat Res; 1996 Apr; 145(4):449-56. PubMed ID: 8600505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of p53, MDM2, and H-ras genes in osteosarcoma and malignant fibrous histiocytoma of bone in patients older than 40 years.
    Kawaguchi K; Oda Y; Sakamoto A; Saito T; Tamiya S; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2002 Aug; 15(8):878-88. PubMed ID: 12181274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDM2 Amplification in Intrahepatic Cholangiocarcinomas: Its Relationship With Large-Duct Type Morphology and Uncommon KRAS Mutations.
    Kim SJ; Akita M; Sung YN; Fujikura K; Lee JH; Hwang S; Yu E; Otani K; Hong SM; Zen Y
    Am J Surg Pathol; 2018 Apr; 42(4):512-521. PubMed ID: 29309301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational landscape of intrahepatic cholangiocarcinoma.
    Zou S; Li J; Zhou H; Frech C; Jiang X; Chu JS; Zhao X; Li Y; Li Q; Wang H; Hu J; Kong G; Wu M; Ding C; Chen N; Hu H
    Nat Commun; 2014 Dec; 5():5696. PubMed ID: 25526346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of MDM2 protein in intrahepatic cholangiocarcinoma: relationship with p53 overexpression, Ki-67 labeling, and clinicopathological features.
    Horie S; Endo K; Kawasaki H; Terada T
    Virchows Arch; 2000 Jul; 437(1):25-30. PubMed ID: 10963376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand.
    Kiba T; Tsuda H; Pairojkul C; Inoue S; Sugimura T; Hirohashi S
    Mol Carcinog; 1993; 8(4):312-8. PubMed ID: 8280380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genotyping of multiple genetic alterations of intrahepatic cholangiocarcinoma].
    Cong W; Wu M; Chen H
    Zhonghua Yi Xue Za Zhi; 2001 Mar; 81(5):271-3. PubMed ID: 11798885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between genetic alterations and clinicopathological features in intrahepatic cholangiocarcinoma].
    Cong W; Finkelstein SD; Wu M
    Zhonghua Bing Li Xue Za Zhi; 2001 Jun; 30(3):183-7. PubMed ID: 11866974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of p53 gene mutation and expression of P53 protein in cholangiocarcinoma.
    Liu XF; Zhang H; Zhu SG; Zhou XT; Su HL; Xu Z; Li SJ
    World J Gastroenterol; 2006 Aug; 12(29):4706-9. PubMed ID: 16937443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection and clinical pathological significance of the expression of P21, P185, p53 proteins and mutation of ras, p53 genes in transitional cell carcinoma of the bladder].
    Yu D; Liu F; Liang Z
    Zhonghua Bing Li Xue Za Zhi; 1996 Aug; 25(4):202-5. PubMed ID: 9275651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of microsatellite instability, K-ras gene mutation and p53 protein overexpression in intrahepatic cholangiocarcinoma.
    Isa T; Tomita S; Nakachi A; Miyazato H; Shimoji H; Kusano T; Muto Y; Furukawa M
    Hepatogastroenterology; 2002; 49(45):604-8. PubMed ID: 12063950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ki-ras mutations in codon 12 and p53 mutations (biomarkers) and cytology in bile in patients with hepatobiliary-pancreatic carcinoma.
    Yamaguchi K; Nakano K; Nagai E; Chijiiwa K; Kinoshita M; Ohta M; Tanaka M
    Hepatogastroenterology; 2005; 52(63):713-8. PubMed ID: 15966189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.